Multiple Sclerosis l: Introduction
Drugs for Treatment of Ulcerative Colitis in IBD
Parkinson's Disease: Treatment
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 1, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
1Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland, aiden.haghikia@rub.de.
Fumaric acid, a new oral therapy for relapsing remitting multiple sclerosis (MS), offers immunomodulatory and tissue-protective effects. This review aids clinicians in selecting baseline MS treatments by examining fumaric acid
Area of Science:
04:41Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017